Table 2.
Comparison of fasting glucose (after excluding diabetic patients) and cholesterol levels (after excluding patients taking cholesterol medication) among ADT users and controls
| Variable | ADT users | Controls | p value |
|---|---|---|---|
| Glucose (mmol/L) | n = 29 | n = 31 | |
| Mean glucose (SD) | 5.88 (0.56) | 5.52 (0.61) | 0.024 |
| Range | 4.80–7.10 | 4.50–7.10 | |
| Cholesterol (mmol/L) | n = 20 | n = 25 | |
| Mean total cholesterol (SD) | 5.31 (1.2) | 4.93 (1.2) | 0.31 |
| Range | 3.09–6.84 | 2.92–7.09 | |
| Mean HDL (SD) | 1.38 (0.52) | 1.30 (0.35) | 0.55 |
| Range | 0.80–2.65 | 0.79–2.28 | |
| Mean LDL (SD) | 3.40 (0.71) | 3.10 (1.0) | 0.36 |
| Range | 2.34–4.60 | 1.60–5.14 | |
| Mean triglycerides (SD) | 1.63 (0.89) | 1.23 (0.63) | 0.12 |
| Range | 0.43–2.78 | 0.69–3.17 |
HDL: high-density lipoprotein; LDL: low-density lipoprotein; SD: standard deviation; ADT: androgen deprivation therapy.